HealthCare Global Enterprises Limited (HCG) announced a follow-up Board meeting scheduled for February 24, 2026. The primary purpose is to determine the specifics of the previously approved Rights Issue, which aims to raise up to ₹42,500 Lakhs. Key parameters to be finalized include the Rights Issue price, entitlement ratio, payment mechanisms, and the official record date for eligible shareholders.
Follow-up Board Meeting Announced
Following the initial disclosure on February 17, 2026, HealthCare Global Enterprises Limited has formally announced a subsequent meeting of the Board of Directors. This meeting is scheduled to convene on February 24, 2026.
Purpose: Finalizing Rights Issue Terms
The primary agenda for this session is to discuss, consider, and decide on the definitive terms related to the previously approved Rights Issue. The Board intends to raise an aggregate amount not exceeding ₹42,500 Lakhs (Rupees Forty Two Thousand and Five Hundred Lakhs) through the issue of equity shares with a face value of ₹10 each to eligible shareholders.
The specific critical matters that require finalization during the meeting include:
- Determination of the Rights Issue price.
- Setting the rights entitlement ratio.
- Establishing the mechanism for related payment procedures.
- Finalizing the official record date and timing for the Rights Issue.
These decisions are subject to securing the necessary in-principle approvals from the relevant stock exchanges and other applicable regulatory bodies before proceeding.
Source: BSE
